Evidence map›Paper›PMID 17316467›Full record

ArticleCritical care (London, England)2007

Pharmacotherapy during neonatal extracorporeal membrane oxygenation: toward an evidence-based approach.

Maissa Rayyan, Karel Allegaert

Open access · goldAbstract readComment
In one paragraph

Article in Critical care (London, England), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maissa RayyanDepartment of Woman and Child, University of Leuven, Herestraat 49, 3000 Leuven, Belgium. maissa.rayyan@uz.kuleuven.ac.be
Karel Allegaert
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Van der Vorst and coworkers recently illustrated the large variability in furosemide regimens used in their unit. This finding at least suggests that we need more data on the pharmacokinetics and pharmacodynamics of this drug in neonates during treatment with extracorporeal membrane oxygenation, in order to ensure quality of care and safety, and to promote evidence-based prescription. The implementation of population pharmacokinetic models can further increase both the feasibility of such studies and the relevance of the results generated.

Indexed as

Extracorporeal Membrane OxygenationDiureticsFurosemideHumansInfantInfant, NewbornDiureticsFurosemide

Identifiers

PMID17316467
PMCPMC2151886
OpenAlexW2143118780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.